In addition, the macrophage test was positive in two of 45 non-exposed control subjects.
mately 600% of healthy beryllium workers, but the PPD macrophage test was only positive in 7 %.
We conclude that the Be lymphocyte transformation test is the most sensitive and reproducible and advocate its use in the diagnosis of disease and in monitoring the health of potentially exposed workers.
Delayed-type hypersensitivity reactions may be measured in vitro using lymphocyte cultures.' These tests are particularly relevant to beryllium disease as they avoid skin testing with an extremely potent sensitiser. Hypersensitivity is an important feature of chronic beryllium disease, and although not diagnostic, is of value in diagnosis.2 Other applications of in vitro beryllium hypersensitivity tests include: (a) screening tests to detect the development of sensitivity in potentially exposed workers, who may be at increased risk of developing disease; (b) as an indicator of industrial hygiene standard.
Two in vitro tests, macrophage migration inhibition and lymphocyte transformation, have been reported to be of value for detecting beryllium hypersensitivity (Table 1) Lymphocyte supernatants (lymphokines) were concentrated ( x 3 -x 39) as follows. Lymphocytes were cultured for one to three days in flat-bottomed plastic tubes with or without PPD (5 ,ug/ml). The medium was changed daily, pooled and control medium reconstituted with PPD prior to filtration (pore size < 0-2 ,um) and dialysed. Of three patients previously reported as macrophage migration-positive3 6 only one was positive on this occasion. Table 4 ).
In all 72 workers, the lymphocyte transformation results were negative.
Control population
The macrophage test was positive in two of 45 (4%) subjects with no known beryllium exposure.
TUBERCULIN ANTIGEN
The PPD lymphocyte transformation test (Table 4) was positive in 58 % of the healthy factory population and in all seven patients with chronic beryllium disease. The PPD macrophage test, however, showed a very low positive rate (7 %) in the factory population.
In addition, the tuberculin macrophage test was only positive in one of six patients with tuberculosis and in only two of 45 of the control group.
The modified tuberculin macrophage migration inhibition test in patients with tuberculosis was positive in only two (0-4 and 0-74) of 12 using threeWilliams, Williams day culture supernatants and in only one (0 79) of four using one-day cultures, and were independent of lymphokine and PPD concentrations. In tuberculin skin-positive subjects there were no positive results (0 of 6) using one-day culture supernatants, and only one (0-78) of five was positive with three-day culture supernatants. This test was again therefore unsatisfactory.
Discussion
Our comparison of two in vitro beryllium hypersensitivity tests have demonstrated the advantages of the lymphocyte transformation test. The beryllium transformation test gave a positive result in all seven patients with chronic beryllium disease, and was independent of steroid therapy. In contrast, the Be macrophage test was not reproducible and in three patients, two on steroids, gave negative results.
In healthy potentially exposed workers, from two factories, the Be transformation test was negative in all 72 tested. The Be macrophage test was positive in four of 78 (3 %) and of two retested, one was negative.
These positive workers were indistinguishable from those with negative results, as regards details of potential exposure and length of employment, and showed no evidence of beryllium or other disease.
Although the two factories were using beryllium in different manufacturing processes, the results of both Be tests and the PPD macrophage test were very similar. Positive PPD transformation tests were, however, fewer in the ceramic factory (50%) than in the machining factory (65 %). In the control healthy subjects, the Be macrophage test was positive in two subjects (4%), neither of which had any known beryllium exposure.
The reliability of the tests was also assessed using tuberculin. The PPD transformation test was positive in 58 % of the healthy factory workers. This incidence compares with the 60% positive Mantoux reaction found in the factory 1 population.6 The PPD macrophage test gave an unacceptably low positive rate in the factory population, tuberculosis patients and Mantoux-positive subjects. Attempts to improve the technique by concentrating lymphokine supernatants were ineffective. Loss of sensitivity may be associated with dialysis of lymphokine preparations which tend to disrupt MIF molecules. '4 We conclude that the lymphocyte transformation test is superior to the macrophage migration inhibition assay as a means of detection of hypersensitivity using both beryllium and tuberculin antigen. Also, the transformation tests is technically easier and does not require laboratory animals. We therefore advocate the use of the beryllium lymphocyte transformation test in the diagnosis of beryllium disease and in monitoring the health of potentially exposed workers. 
